Preclinical Development of Lentiviral Vector Gene Therapy for Diamond-Blackfan Anemia Syndrome

To facilitate lentiviral vector design, optimize transduction and assess potential therapeutic efficacy, researchers leveraged a human cellular model of Diamond-Blackfan anemia syndrome based on heterozygous disruption of RPS19 in healthy donor CD34+ hematopoietic stem/progenitor cells.